Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474

van Esbroeck, Annelot C. M., Janssen, Antonius P. A., Cognetta, Armand B., Ogasawara, Daisuke, Shpak, Guy, van der Kroeg, Mark, Kantae, Vasudev, Baggelaar, Marc P. +21 more·2017·Science
DOI 10.1126/science.aaf7497

Cited by (344)

Items 101–200 of 344

  1. Brain permeant and impermeant inhibitors of fatty-acid amide hydrolase suppress the development and maintenance of paclitaxel-induced neuropathic pain without producing tolerance or physical dependence in vivo and synergize with paclitaxel to reduce tumor cell line viability in vitro
    Richard A. Slivicki, Zhili Xu, Sonali S. Mali, Andrea G. Hohmann · 2019 · Pharmacological Research
  2. Antidepressant-like effects of pharmacological inhibition of FAAH activity in socially isolated female rats
    Luca Carnevali, Rosario Statello, Federica Vacondio, Francesca Ferlenghi, Gilberto Spadoni, Silvia Rivara, Marco Mor, Andrea Sgoifo · 2020 · European Neuropsychopharmacology
  3. Activity‐Based Protein Profiling (ABPP) of Oxidoreductases
    Rita Fuerst, Rolf Breinbauer · 2020 · ChemBioChem
  4. Chemical Probes to Control and Visualize Lipid Metabolism in the Brain
    Jeroen M. Punt, Daan van der Vliet, Mario van der Stelt · 2022 · Accounts of Chemical Research
  5. New Approaches to Cancer Therapy: Combining Fatty Acid Amide Hydrolase (FAAH) Inhibition with Peroxisome Proliferator-Activated Receptors (PPARs) Activation
    Leonardo Brunetti, Fulvio Loiodice, Luca Piemontese, Paolo Tortorella, Antonio Laghezza · 2019 · Journal of Medicinal Chemistry
  6. Biosynthetic origins of unusual cannabimimetic phytocannabinoids in Cannabis sativa L: A review
    Matthew T. Welling, Myrna A. Deseo, Antony Bacic, Monika S. Doblin · 2022 · Phytochemistry
  7. The endocannabinoid system in migraine: from bench to pharmacy and back
    Cristina Tassorelli, Rosaria Greco, Stephen David Silberstein · 2019 · Current Opinion in Neurology
  8. Etomoxir repurposed as a promiscuous fatty acid mimetic chemoproteomic probe
    Joseph M. Choi, Danielle M. Smith, Ye Jin Lee, Danfeng Cai, Mohammad J. Hossain, Tamara J. O’Connor, Pragney Deme, Norman J. Haughey, Susanna Scafidi, Ryan C. Riddle et al. · 2024 · iScience
  9. Activity-Based Protein Profiling Identifies α-Ketoamides as Inhibitors for Phospholipase A2 Group XVI
    Juan Zhou, Elliot D. Mock, Andrea Martella, Vasudev Kantae, Xinyu Di, Lindsey Burggraaff, Marc P. Baggelaar, Karol Al Ayed, Alexander T. Bakker, Bogdan I. Florea et al. · 2019 · ACS Chemical Biology
  10. N-Acyl pyrazoles: Effective and tunable inhibitors of serine hydrolases
    Katerina Otrubova, Shreyosree Chatterjee, Srijana Ghimire, Benjamin F. Cravatt, Dale L. Boger · 2019 · Bioorganic & Medicinal Chemistry
  11. Safety, Tolerability, and Pharmacokinetics of FAAH Inhibitor BIA 10‐2474: A Double‐Blind, Randomized, Placebo‐Controlled Study in Healthy Volunteers
    José‐Francisco Rocha, A. Santos, Helena Gama, Paul C. Moser, Amílcar C. Falcão, Peter Pressman, Andrew Wallace Hayes, Patrı́cio Soares-da-Silva · 2021 · Clinical Pharmacology & Therapeutics
  12. Safety Surveillance During Drug Development: Comparative Evaluation of Existing Regulations
    Chrysanthi Samara, Alix Garcia, Christopher Henry, Laure Vallotton, Luca Cariolato, Jules Alexandre Desmeules, Alexis Pinçon · 2023 · Advances in Therapy
  13. Discovery of a Potent Deubiquitinase (DUB) Small‐Molecule Activity‐Based Probe Enables Broad Spectrum DUB Activity Profiling in Living Cells**
    Daniel Conole, Fangyuan Cao, Christopher W. am Ende, Liang Xue, Sheila Kantesaria, Dahye Kang, Jun Hong Jin, Dafydd R. Owen, Linda Lohr, Monica Schenone et al. · 2023 · Angewandte Chemie International Edition
  14. Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain
    Margherita Brindisi, Giuseppe Borrelli, Simone Brogi, Alessandro Grillo, Samuele Maramai, Marco Paolino, Mascia Benedusi, Alessandra Pecorelli, Giuseppe Valacchi, Lorenzo Di Cesare Mannelli et al. · 2018 · ChemMedChem
  15. Identification of α,β-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells
    Annelot C. M. van Esbroeck, Vasudev Kantae, Xinyu Di, Tom van der Wel, Hans den Dulk, Anna Floor Stevens, Simar J. Singh, Alexander T. Bakker, Bogdan I. Florea, Nephi Stella et al. · 2019 · Frontiers in Molecular Neuroscience
  16. Development of Activity-Based Chemical Probes for Human Sirtuins
    Elysian Graham, Stacia Rymarchyk, Marci Wood, Yana Cen · 2018 · ACS Chemical Biology
  17. Discovery of a Potent, Long‐Acting, and CNS‐Active Inhibitor (BIA 10‐2474) of Fatty Acid Amide Hydrolase
    László E. Kiss, А. Н. Беляев, Humberto S. Ferreira, Carla P. Rosa, Maria João Bonifácio, Ana I. Loureiro, Nuno Marques Pires, P. Nuno Palma, Patrı́cio Soares-da-Silva · 2018 · ChemMedChem
  18. Alcohol-Endocannabinoid Interactions: Implications for Addiction-Related Behavioral Processes
    Antonia Serrano · 2022 · Alcohol research
  19. Synergism between the Synthetic Antibacterial and Antibiofilm Peptide (SAAP)-148 and Halicin
    Miriam E. van Gent, Tanny J. K. van der Reijden, Patrick R. Lennard, Adriëtte W. de Visser, Bep Ravensbergen, Natasja Dolezal, Robert A. Cordfunke, Jan Wouter Drijfhout, Peter H. Nibbering · 2022 · Antibiotics
  20. Die molekulare industrielle Revolution: zur automatisierten Synthese organischer Verbindungen
    Melanie Trobe, Martin D. Burke · 2018 · Angewandte Chemie
  21. Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place?
    Giacomo Giacovazzo, Tiziana Bisogno, Fabiana Piscitelli, Roberta Verde, Sergio Oddi, Mauro Maccarrone, Roberto Coccurello · 2019 · International Journal of Molecular Sciences
  22. Bioorthogonal Reactions in Activity-Based Protein Profiling
    Steven H. L. Verhelst, Kimberly M. Bonger, Lianne I. Willems · 2020 · Molecules
  23. Technologies for Direct Detection of Covalent Protein–Drug Adducts
    Elma Mons, Robbert Q. Kim, Monique P. C. Mulder · 2023 · Pharmaceuticals
  24. A Simplified Thermal Proteome Profiling Approach to Screen Protein Targets of a Ligand
    Xiaolei Zhang, Chengfei Ruan, He Zhu, Kejia Li, Wenbo Zhang, Keyun Wang, Lianghai Hu, Mingliang Ye · 2020 · PROTEOMICS
  25. The Endocannabinoid System and Cannabidiol: Past, Present, and Prospective for Cardiovascular Diseases
    Martina Rabino, Sara Mallia, Elisa Castiglioni, Davide Rovina, Giulio Pompilio, Aoife Gowran · 2021 · Pharmaceuticals
  26. Development of N-(1-Adamantyl)benzamides as Novel Anti-Inflammatory Multitarget Agents Acting as Dual Modulators of the Cannabinoid CB2 Receptor and Fatty Acid Amide Hydrolase
    Francesca Intranuovo, Leonardo Brunetti, Pietro Delre, Giuseppe Felice Mangiatordi, Angela Stefanachi, Antonio Laghezza, Mauro Niso, Francesco Leonetti, Fulvio Loiodice, Alessia Ligresti et al. · 2022 · Journal of Medicinal Chemistry
  27. Opportunities and challenges for the development of covalent chemical immunomodulators
    Keriann M. Backus, Jian Xin Cao, Sean M. Maddox · 2019 · Bioorganic & Medicinal Chemistry
  28. Development of a Retinal-Based Probe for the Profiling of Retinaldehyde Dehydrogenases in Cancer Cells
    Sebastiaan T. A. Koenders, Lukas S. Wijaya, Martje N. Erkelens, Alexander T. Bakker, Vera E. van der Noord, Eva J. van Rooden, Lindsey Burggraaff, Pasquale C. Putter, Else Botter, Kim Wals et al. · 2019 · ACS Central Science
  29. Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold?
    Domenico Fazio, Emanuele Criscuolo, Alessandra Piccoli, Barbara Barboni, Filomena Fezza, Mauro Maccarrone · 2020 · Expert Opinion on Drug Discovery
  30. Untapped endocannabinoid pharmacological targets: Pipe dream or pipeline?
    Jenny L. Wilkerson, Joshua A. Bilbrey, Jasmine S. Felix, Alexandros Makriyannis, Lance Richard McMahon · 2021 · Pharmacology Biochemistry and Behavior
  31. Molecular basis of FAAH-OUT -associated human pain insensitivity
    Hajar Mikaeili, Abdella M. Habib, Charlix Yeung, Sonia Santana‐Varela, Ana Paula Luiz, Kseniia Panteleeva, Sana R. Zuberi, Alkyoni Athanasiou‐Fragkouli, Henry Houlden, John N. Wood et al. · 2023 · Brain
  32. Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder
    Gaurav Bedse, Samuel W. Centanni, Danny G. Winder, Sachin Patel · 2019 · Alcoholism Clinical and Experimental Research
  33. ABHD2 Inhibitor Identified by Activity-Based Protein Profiling Reduces Acrosome Reaction
    Marc P. Baggelaar, Hans den Dulk, Bogdan I. Florea, Domenico Fazio, Nicola Bernabò, Marcello Raspa, Antonius P. A. Janssen, Ferdinando Scavizzi, Barbara Barboni, Herman S. Overkleeft et al. · 2019 · ACS Chemical Biology
  34. Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions
    Marta Vázquez, Carlos García‐Carnelli, Cecilia Maldonado, Pietro L. Fagiolino · 2021 · Advances in experimental medicine and biology
  35. Reverse-Design toward Optimized Labeled Chemical Probes – Examples from the Endocannabinoid System
    Mónica Guberman, Miroslav Kosar, Anahid Omran, Erick M. Carreira, Marc Nazaré, Uwe Grether · 2022 · CHIMIA International Journal for Chemistry
  36. Discovery of heterocyclic carbohydrazide derivatives as novel selective fatty acid amide hydrolase inhibitors: design, synthesis and anti-neuroinflammatory evaluation
    Yanguo Shang, Qingjing Hao, Kaixuan Jiang, Mengting He, Jinxin Wang · 2020 · Bioorganic & Medicinal Chemistry Letters
  37. Cleavable linkers and their application in MS-based target identification
    Hester A. Beard, Dimitris Korovesis, Suyuan Chen, Steven H. L. Verhelst · 2021 · Molecular Omics
  38. Druggable targets of the endocannabinoid system: Implications for the treatment of HIV-associated neurocognitive disorder
    Mariah M. Wu, Xinwen Zhang, Melissa J. Asher, Stanley A. Thayer · 2019 · Brain Research
  39. Fatty Acid Amide Hydrolase: An Integrative Clinical Perspective
    Anugrah Dianfitriani Santoso, Dirk J. M. K. De Ridder · 2022 · Cannabis and Cannabinoid Research
  40. Lipid-metabolizing serine hydrolases in the mammalian central nervous system: endocannabinoids and beyond
    Myungsun Shin, Timothy B. Ware, Hyeon‐Cheol Lee, Ku‐Lung Hsu · 2018 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
  41. Docking-Based 3D-QSAR Studies for 1,3,4-oxadiazol-2-one Derivatives as FAAH Inhibitors
    Agata Zięba, Tuomo Laitinen, Jayendra Z. Patel, Antti Poso, Agnieszka Anna Kaczor · 2021 · International Journal of Molecular Sciences
  42. Covalent Recruitment of NEDD4 for Targeted Protein Degradation: Rational Design of Small Molecular Degraders
    Xiaoqiang He, Shihan Zeng, Yalei Wen, Tao Yang, Chaoming Huang, Yi-Fang Li, Zhang Zhang, Ke Ding, Tongzheng Liu, Yi Tan et al. · 2025 · Journal of the American Chemical Society
  43. Assessment of a 3D neural spheroid model to detect pharmaceutical-induced neurotoxicity
    Qin Lin Wang · 2022 · ALTEX
  44. Novel Tetrafunctional Probes Identify Target Receptors and Binding Sites of Small-Molecule Drugs from Living Systems
    Rin Miyajima, Koji Sakai, Yuki Otani, Takashi Wadatsu, Yasuyo Sakata, Yuki Nishikawa, Masaki Tanaka, Yu Yamashita, Mikayo Hayashi, Kazumi Kondo et al. · 2020 · ACS Chemical Biology
  45. Site-Specific Activity-Based Protein Profiling Using Phosphonate Handles
    Wouter van Bergen, Johannes F. Hevler, Wei Wu, Marc P. Baggelaar, Albert J. R. Heck · 2022 · Molecular & Cellular Proteomics
  46. Preclinical pharmacological evaluation of the fatty acid amide hydrolase inhibitor BIA 10‐2474
    Maria João Bonifácio, Filipa Sousa, Cátia C.P. Aires, Ana I. Loureiro, Carlos Fernandes‐Lopes, Nuno Marques Pires, P. Nuno Palma, Paul C. Moser, Patrı́cio Soares-da-Silva · 2020 · British Journal of Pharmacology
  47. Chemical genetics strategy to profile kinase target engagement reveals role of FES in neutrophil phagocytosis
    Tom van der Wel, Riet Hilhorst, Hans den Dulk, Tim van den Hooven, Nienke Prins, Joost J.A.P.M. Wijnakker, Bogdan I. Florea, Eelke Bart Lenselink, Gerard J. P. van Westen, Rob Ruijtenbeek et al. · 2020 · Nature Communications
  48. Structure–Activity Relationship Studies of α-Ketoamides as Inhibitors of the Phospholipase A and Acyltransferase Enzyme Family
    Juan Zhou, Elliot D. Mock, Karol Al Ayed, Xinyu Di, Vasudev Kantae, Lindsey Burggraaff, Anna Floor Stevens, Andrea Martella, Florian Mohr, Ming Jiang et al. · 2020 · Journal of Medicinal Chemistry
  49. Druggable Targets in Endocannabinoid Signaling
    Ann M. Gregus, Matthew W. Buczynski · 2020 · Advances in experimental medicine and biology
  50. Enhancing Endocannabinoid Signaling via β-Catenin in the Nucleus Accumbens Attenuates PTSD- and Depression-like Behavior of Male Rats
    Tomer Mizrachi Zer‐Aviv, Larglinda Islami, Peter J. Hamilton, Eric M. Parise, Eric J. Nestler, Brenda Sbarski, Irit Akirav · 2022 · Biomedicines
  51. The Role of Quantitative Systems Pharmacology in the Design of First‐in‐Human Trials
    Piet H. van der Graaf, Neil Benson · 2018 · Clinical Pharmacology & Therapeutics
  52. Better science for safer medicines: the human imperative
    Kathy Archibald, Katya Tsaioun, J. Gerry Kenna, Pandora Pound · 2018 · Journal of the Royal Society of Medicine
  53. The role of endocannabinoids in consolidation, retrieval, reconsolidation, and extinction of fear memory
    Ikumi Mizuno, Shingo Matsuda · 2021 · Pharmacological Reports
  54. A potent and selective inhibitor for the modulation of MAGL activity in the neurovasculature
    Alicia M. Kemble, Benoit Hornsperger, Iris Ruf, Hans Georg Richter, Jörg Benz, Bernd Kuhn, Dominik Heer, Matthias Wittwer, Britta Engelhardt, Uwe Grether et al. · 2022 · PLoS ONE
  55. Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options
    J. Daniel Lafreniere, Melanie E.M. Kelly · 2018 · Neuronal Signaling
  56. Benzylamides and piperazinoarylamides of ibuprofen as fatty acid amide hydrolase inhibitors
    Alessandro Deplano, Mariateresa Cipriano, Federica Moraca, Ettore Novellino, Bruno Catalanotti, Christopher John Fowler, Valentina Onnis · 2019 · Journal of Enzyme Inhibition and Medicinal Chemistry
  57. Therapeutic potential of targeting α/β-Hydrolase domain-containing 6 (ABHD6)
    Hui Deng, Weimin Li · 2020 · European Journal of Medicinal Chemistry
  58. EFMC: Trends in Medicinal Chemistry and Chemical Biology
    Yves P. Auberson, Paola Barbara Arimondo, Maria Duca, Sebastian Essig, Uwe Grether, Arne Christian Rufer, Gianluca Sbardella, Ulrich Schopfer, Antoni Torrens, Mario van der Stelt et al. · 2023 · ChemBioChem
  59. Structure Kinetics Relationships and Molecular Dynamics Show Crucial Role for Heterocycle Leaving Group in Irreversible Diacylglycerol Lipase Inhibitors
    Antonius P. A. Janssen, Jacob M. A. van Hengst, Olivier J. M. Béquignon, Hui Deng, Gerard J. P. van Westen, Mario van der Stelt · 2019 · Journal of Medicinal Chemistry
  60. Developmental and reproductive toxicity studies of BIA 10-2474
    Stephen B. Harris, Jerry F. Hardisty, Andrew Wallace Hayes, Klaus Weber · 2019 · Regulatory Toxicology and Pharmacology
  61. Endocannabinoid Hydrolase Inhibitors: Potential Novel Anxiolytic Drugs
    Hongqing Zhao, Yang Liu, Na Cai, Xiaolin Liao, Lin Tang, Yuhong Wang · 2024 · Drug Design Development and Therapy
  62. Oral repeated-dose toxicity studies of BIA 10–2474 in Wistar rat
    Andrew Wallace Hayes, Jerry F. Hardisty, Stephen B. Harris, Yoshimasa Okazaki, Klaus Weber · 2019 · Regulatory Toxicology and Pharmacology
  63. Oral repeated-dose toxicity studies of BIA 10–2474 in beagle dogs
    Jerry F. Hardisty, Stephen B. Harris, Andrew Wallace Hayes, Klaus Weber · 2019 · Regulatory Toxicology and Pharmacology
  64. Choosing the right drug: status and future of endocannabinoid research for the prevention of drug-seeking reinstatement
    Miguel Ángel Luján, Joseph F. Cheer, Miriam Melis · 2020 · Current Opinion in Pharmacology
  65. Cannabinoide in der Schmerzmedizin
    Matthias Karst · 2018 · Der Schmerz
  66. The Impact of Activity‐Based Protein Profiling in Malaria Drug Discovery
    Luís A. R. Carvalho, Gonçalo J. L. Bernardes · 2022 · ChemMedChem
  67. Metabolic profiling of material-limited cell samples by dimethylaminophenacyl bromide derivatization with UPLC-MS/MS analysis
    Cornelius C.W. Willacey, Naama Karu, Amy C. Harms, Thomas Hankemeier · 2020 · Microchemical Journal
  68. Development of indole-2-carbonyl piperazine urea derivatives as selective FAAH inhibitors for efficient treatment of depression and pain
    Yanguo Shang, Minghui Wang, Qingjing Hao, Tao Meng, Lili Li, Junwei Shi, Guoqing Yang, Zhilan Zhang, Kan Yang, Jinxin Wang · 2022 · Bioorganic Chemistry
  69. Proteomics and Lipidomics in the Elucidation of Endocannabinoid Signaling in Healthy and Schizophrenia Brains
    Gabriela Seabra, Ana Caroline Brambilla Falvella, Paul C. Guest, Daniel Martins‐de‐Souza, Valéria de Almeida · 2018 · PROTEOMICS
  70. Emerging Roles of Cannabinoids and Synthetic Cannabinoids in Clinical Experimental Models
    Paula Morales, Patricia H. Reggio · 2020 · Advances in experimental medicine and biology
  71. The endocannabinoid system as a therapeutic target for schizophrenia: Failures and potentials
    Alexandre Seillier · 2021 · Neuroscience Letters
  72. New Cysteine Covalent Modification Strategies Enable Advancement of Proteome‐wide Selectivity of Kinase Modulators
    Ivy A. Guan, Kayla Williams, Jolyn Pan, Xuyu Liu · 2021 · Asian Journal of Organic Chemistry
  73. Phenelzine-based probes reveal Secernin-3 is involved in thermal nociception
    Katelyn A. Bustin, Kyosuke Shishikura, Irene Chen, Zongtao Lin, Nate R. McKnight, Yuxuan Chang, Xie Wang, Jing Jing Li, Eric Arellano, Liming Pei et al. · 2023 · Molecular and Cellular Neuroscience
  74. Structure-Guided Discovery of cis-Hexahydro-pyrido-oxazinones as Reversible, Drug-like Monoacylglycerol Lipase Inhibitors
    Bernd Kuhn, Martin Ritter, Benoit Hornsperger, Charles Bell, Buelent Koçer, Didier Rombach, Marius D. R. Lutz, Luca B. Gobbi, Martin Kuratli, Christian Bartelmus et al. · 2024 · Journal of Medicinal Chemistry
  75. Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment
    Nikki Bozinoff, Bernard Le Foll · 2018 · Expert Review of Respiratory Medicine
  76. Synthesis and Biological Evaluation of Endocannabinoid Uptake Inhibitors Derived from WOBE437
    Patrick Mäder, Ruben Bartholomäus, Simon Nicolussi, Alice Baumann, Melanie Weis, Andrea Chicca, Mark Rau, Ana Catarina Simão, Jürg Gertsch, Karl‐Heinz Altmann · 2020 · ChemMedChem
  77. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASP3652, a Reversible Fatty Acid Amide Hydrolase Inhibitor, in Healthy, Nonelderly, Japanese Men and Elderly, Japanese Men and Women: A Randomized, Double-blind, Placebo-controlled, Single and Multiple Oral Dose, Phase I Study
    Masaomi Takizawa, Toshifumi Hatta, Hiromi Iitsuka, Masataka Katashima, Yuichiro Z. Sato, Kentaro Kuroishi, Hirotaka Nagashima · 2020 · Clinical Therapeutics
  78. The absence of genotoxicity of a novel fatty acid amide hydrolase inhibitor, BIA 10–2474
    Andrew Wallace Hayes, Jerry F. Hardisty, Stephen B. Harris, Klaus Weber · 2019 · Regulatory Toxicology and Pharmacology
  79. Deciphering Drug Targets and Actions with Single-Cell and Spatial Resolution
    Zhengyuan Pang, Benjamin F. Cravatt, Ye Li · 2023 · The Annual Review of Pharmacology and Toxicology
  80. DABCO‐Mediated C−O Bond Formation from Csp2‐Halogen Bond‐Containing Compounds and Alkyl Alcohols
    Han‐Qing Wu, Shi‐He Luo, Liang Cao, Haonan Shi, Bo‐Wen Wang, Zhao‐Yang Wang · 2018 · Asian Journal of Organic Chemistry
  81. Probing the chemical–biological relationship space with the Drug Target Explorer
    Robert J. Allaway, Salvatore La Rosa, Justin Guinney, Sara J.C. Gosline · 2018 · Journal of Cheminformatics
  82. Characterization of a monoacylglycerol lipase in the medicinal leech, Hirudo verbana
    Emily J. Kabeiseman, Riley T. Paulsen, Brian D. Burrell · 2020 · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology
  83. On the Biomedical Properties of Endocannabinoid Degradation and Reuptake Inhibitors: Pre-clinical and Clinical Evidence
    Karen Jaqueline Paredes-Ruiz, Karla Chavira-Ramos, Mario Orozco‐Morales, Çi̇men Karasu, Alexey A. Tinkov, Michael Aschner, Abel Santamarı́a, Ana Laura Colín-González · 2021 · Neurotoxicity Research
  84. De‐risking Clinical Trials: The BIAL Phase I Trial in Foresight
    Adam F. Cohen, Jeroen van Smeden, David John Webb · 2021 · Clinical Pharmacology & Therapeutics
  85. Foamy microglia link oxylipins to disease progression in multiple sclerosis
    van der Vliet, Daan, Di, Xinyu, Shamorkina, Tatiana M., Coulon-Bainier, Claire, Pavlovic, Anto, van der Vliet, Iris A. C. M., Zeng, Yingyu, Macnair, Will, van Egmond, Noëlle, Chen, J. Q. Alida et al. · 2026 · Nature Neuroscience
  86. The Effect of Phytocannabinoids and Endocannabinoids on Nrf2 Activity in the Central Nervous System and Periphery
    Pietro Marini, Mauro Maccarrone, Luciano Saso, Paolo Tucci · 2024 · Neurology International
  87. CellEKT: A Robust Chemical Proteomics Workflow to Profile Cellular Target Engagement of Kinase Inhibitors
    Joel Rüegger, Berend Gagestein, Antonius P. A. Janssen, Alexandra Valeanu, Alger Lazo Mori, Marielle van der Peet, Michael S. Boutkan, Bogdan I. Florea, Alex A. Henneman, Remo Hochstrasser et al. · 2025 · Molecular & Cellular Proteomics
  88. FAAH Modulators from Natural Sources: A Collection of New Potential Drugs
    Catalin Nicoara, Filomena Fezza, Mauro Maccarrone · 2025 · Cells
  89. Mapping cellular targets of covalent cancer drugs in the entire mammalian body
    Zhengyuan Pang, Verina H. Leung, Cailynn C. Wang, Ahmadreza Attarpour, Anthony Rinaldi, Hanbing Shen, María Dolores Moya-Garzón, Logan H. Sigua, Claire Rammel, Alexandra Selke et al. · 2025 · Cell
  90. Activity‐Based Protein Profiling in Methicillin‐Resistant Staphylococcus aureus Reveals the Broad Reactivity of a Carmofur‐Derived Probe
    Md Jalal Uddin, Herman S. Overkleeft, Christian Stephan Lentz · 2023 · ChemBioChem
  91. STA‐55, an Easily Accessible, Broad‐Spectrum, Activity‐Based Aldehyde Dehydrogenase Probe
    Sebastiaan T. A. Koenders, Eva J. van Rooden, Hans van den Elst, Bogdan I. Florea, Herman S. Overkleeft, Mario van der Stelt · 2020 · ChemBioChem
  92. Synthesis and evaluation of dual fatty acid amide hydrolase-monoacylglycerol lipase inhibition and antinociceptive activities of 4-methylsulfonylaniline-derived semicarbazones
    Shivani Jaiswal, Akhilesh Akhilesh, Ankit Uniyal, Vinod K. Tiwari, Senthil Raja Ayyannan · 2022 · Bioorganic & Medicinal Chemistry
  93. Tetrazolylpropan-2-ones as inhibitors of fatty acid amide hydrolase: Studies on structure-activity relationships and metabolic stability
    David Garzinsky, Stefan Zahov, Merlin Ekodo Voundi, Walburga Hanekamp, Matthias Lehr · 2018 · European Journal of Medicinal Chemistry
  94. Docking-Informed Machine Learning for Kinome-wide Affinity Prediction
    Schifferstein, Jordy, Bernatavicius, Andrius, Janssen, Antonius P.A. · 2024 · Journal of Chemical Information and Modeling
  95. Research Review: What we have learned about the endocannabinoid system in developmental psychopathology
    Ryann C. Tansey, Marc D. Ferger, Hilary A. Marusak, Leah M. Mayo · 2025 · Journal of Child Psychology and Psychiatry
  96. In Situ Redox-Omics Decoding of Nanoparticle–Protein Corona Interactions Drives the Mitochondrial Metabolic-Immunological Mechanism in Microglia
    Zekun Chen, Ming Gao Yu, Zhong-Yao Li, Ling-Li Zheng, Jichao Zhang, Ting-Ting Liu, Zhuo Yang, Lei Li, Zhiyuan Lu, Tiantian Wei et al. · 2026 · ACS Nano
  97. Design, synthesis and in vitro and in vivo biological evaluation of flurbiprofen amides as new fatty acid amide hydrolase/cyclooxygenase-2 dual inhibitory potential analgesic agents
    Alessandro Deplano, Jessica Karlsson, Federica Moraca, Mona V. Svensson, Claudia Cristiano, Carmine Marco Morgillo, Christopher John Fowler, Roberto Russo, Bruno Catalanotti, Valentina Onnis · 2021 · Journal of Enzyme Inhibition and Medicinal Chemistry
  98. Two-step activity-based protein profiling of diacylglycerol lipase
    Eva J. van Rooden, Roy M. Kreekel, Thomas Hansen, Antonius P. A. Janssen, Annelot C. M. van Esbroeck, Hans den Dulk, Richard J. B. H. N. van den Berg, Jeroen D. C. Codée, Mario van der Stelt · 2018 · Organic & Biomolecular Chemistry
  99. Chemoproteomic Profiling of an Ibrutinib Analogue Reveals its Unexpected Role in DNA Damage Repair
    Zi Ye, Yankun Wang, Hong Yang Wu, Tong Song, Xixiang Li, Qingsong Liu, Chu Wang · 2020 · ChemBioChem
  100. Evidence for the Endocannabinoid System as a Therapeutic Target in the Treatment of Cannabis Use Disorder
    Erin L. Martin, Aimee L. McRae‐Clark · 2020 · Current Addiction Reports